<!doctype html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  
  
  <link rel="stylesheet" href="/css/franklin.css">
  <link rel="stylesheet" href="/css/basic.css">
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/7.0.0/css/all.min.css">
  <link rel="icon" href="/assets/favicon.png">
   <title>Antibodies and Infantry</title>  
</head>
<body>
  <header>
<div class="blog-name"><a href="/"><img src="/assets/audiommunity_banner.png" width="100%" id="banner"></a></div>

<nav>
  <ul>
    <li><a href="/episodes/">Episodes</a></li>
    <li><a href="https://patreon.com/audiommunity">Support Us!</a></li>
    <li><a href="/about/">About</a></li>
    <li><a href="/feed"><img src="/assets/Rss-feed.svg" width="20px"></a></li>
  </ul>
  <img src="/assets/hamburger.svg" id="menu-icon">
</nav>
</header>

<div class="franklin-content">

    
        <h1>Episode 2 - Antibodies and Infantry</h1>
        <div class="episode-metadata"><div class="metadata-item"><span class="metadata-label">Published: </span><span class="metadata-value">February 24, 2014</span></div><div class="metadata-item"><span class="metadata-label">Duration: </span><span class="metadata-value">1:26:35</span></div><div class="metadata-item"><span class="metadata-label">Topics: </span><div class="metadata-tags"><span class="tag"><a href="/tags/archive/">archive</a></span></div></div></div>
        
<p>
<audio controls preload="metadata">
    <source src="https://archive.org/download/audiommunity_ep002_disclaimer/audiommunity_ep002_disclaimer.mp3" type="audio/mpeg">
    Your browser does not support the audio element.
</audio>
</p>

        <div class="youtube-placeholder"><p>No YouTube video available for this episode</p><p>Visit our <a href="https://youtube.com/@audiommunity" target="_blank">YouTube channel</a> to see videos from other episodes.</p></div>
    

</div>



<div class="franklin-content" >
  <p>In this episode, we're talking antibodies - what they are  and what they have to do with Vaccines. Also, we discuss efforts to use engineered antibodies to treat HIV.</p>
<p>First described by Paul Erlich in the early 20th century, antibodies can bind and neutralize viruses and toxins, or target bacteria for destruction. Antibodies are proteinst that grab their targets (called their "ligand"), through variable regions called "complimentarity determining regions" (CDR).</p>
<p>These CDRs are variable because B-cells re-arrange their genomic DNA, mixing and matching together so-called "V," "D," and "J" (for variable, diversity and joining) gene segments, yielding tens of thousands of different possible combinations.</p>
<p>Even more variability is possible because the junctions between these regions are not perfect, yielding mutations that may change the way that an antibody binds.</p>
<p>In episode 2, we talk about <a href="http://www.ncbi.nlm.nih.gov/pubmed/22932267">a paper</a> that seems to indicate that a particular antibody V region has evolved to bind the stalk of the influenza hemaglutanin spike protein, and <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057367/">a different study</a> that tries to use engineered broadly neutralizing antibodies to treat HIV infections.</p>
<p>&#45;--------------------------</p>
<p><strong>Links:</strong></p>
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/22932267">Influenza antibody paper</a> (presented by Kate)</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057367/">HIV antibody therapy paper</a> (presented by Matt)</li>
</ul>

  <div class="page-foot">
    <a href="http://creativecommons.org/licenses/by-sa/4.0/">CC BY-SA 4.0</a> Audiommunity.org. Last modified: July 28, 2025.
    Website built with <a href="https://github.com/tlienart/Franklin.jl">Franklin.jl</a> and the <a href="https://julialang.org">Julia programming language</a>.
</div>

</div>

    
    
  </body>
</html>
